http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007015999-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d64ea7c3eab5c97df2fbd6ed9f9b9299
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6316f15d5e30360572dc516f95f2367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4b6763aad51c0b800dc493ed85b401a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37d510f7906b892407c697b31542555a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2948bbb5023634b7d23f84cda0370a86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C241-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C241-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
filingDate 2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2aab7a262dfc12369144e2019c73478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3626ea320ec4b96047724bf03773e805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a81285df80f948fdeb23577d44da841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026549dc4b4e62cf837ce45db128c18e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab018d48af2a221d3fee68fc928eb3e1
publicationDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007015999-A3
titleOfInvention Process for synthesizing a substituted pyrazole
abstract The present application relates to a process for the synthesis of the compound of formula 1. The compound of formula I is a glucagon receptor antagonist and is useful for treating, preventing or delaying the onset of type 2 diabetes mellitus.
priorityDate 2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004069158-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6420427-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005121097-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16186314

Total number of triples: 31.